(1 RC) - EPA’s Registered Antimicrobial Products Effective Against Bloodborne Pathogens: Human immunodeficiency virus (HIV), Hepatitis B and Hepatitis C… (EPA, Mar 2024)
(1 RC) - This guideline describes test methods that EPA believes will generally satisfy testing requirements of the Federal Insecticide, Fungicide, and Rodenticide Act and the Federal Food, Drug, and Cosmetic Act. It addresses testing to demonstrate the effectiveness of disinfectant products bearing bactericidal, fungicidal, virucidal, and/or tuberculocidal claims for use on hard surfaces… (EPA, Apr 2010)
(4 RC) - To prevent the spread of human disease, it is necessary to control the growth and abundance of microbes in or on various items frequently used by humans. Inanimate items, such as doorknobs, toys, or towels, which may harbor microbes and aid in disease transmission, are called fomites. Two factors heavily influence the level of cleanliness required for a particular fomite and, hence, the protocol chosen to achieve this level… (Microbiology Chapter 13, 2016)
(.50 RC) - The Australian Government is concerned for those patients who are suffering debilitating symptoms they believe to be associated with exposure to mould and/or biotoxins. At this point in time, further research is required into the link between such symptoms and exposure to mould. The Australian Government acknowledges that there is a need to provide better multidisciplinary care to patients (WHO, Mar 2020)
(4 RC) - This report includes a summary of existing policies on providing healthy environments in schools and kindergartens, an overview of environmental risk factors in schools, information on design, methods and results of selected recently conducted exposure assessment surveys and a summary of pupils’ exposures to major environmental factors, such as selected indoor air pollutants, mold and dampness and poor ventilation in classrooms, sanitation and hygiene problems, smoking and the use of various modes of transportation to school… (WHO, Jan 2015)
(4 RC) - This report includes a summary of existing policies on providing healthy environments in schools and kindergartens, an overview of environmental risk factors in schools, information on design, methods and results of selected recently conducted exposure assessment surveys and a summary of pupils’ exposures to major environmental factors, such as selected indoor air pollutants, mold and dampness and poor ventilation in classrooms, sanitation and hygiene problems, smoking and the use of various modes of transportation to school… (WHO, Jan 2015)
(3 RC) - This report provides CDC recommendations to U.S. health care providers regarding treatment, pre-exposure prophylaxis, and post-exposure prophylaxis of plague. Yersinia pestis, the bacterium that causes plague, leads to naturally occurring disease in the United States and other regions worldwide and is recognized as a potential bioterrorism weapon. A bioweapon attack with Y. pestis could potentially infect thousands, requiring rapid and informed decision making by clinicians and public health agencies.…(CDC MMWR, July 2021)
(.50 RC) - To investigate the effectiveness of portable HEPA air cleaners and universal masking at reducing exposure to exhaled aerosol particles, the investigation team used respiratory simulators to mimic a person with COVID-19 and other, uninfected persons in a conference room. The addition of two HEPA air cleaners that met the Environmental Protection Agency recommended clean air delivery rate… (CDC MMWR, Jul 9 2021)
(.50 RC) - As of April 16, 2021, U.S. correctional and detention facilities reported 399,631 cases of COVID-19 in incarcerated persons, resulting in 2,574 deaths (1). During July 14–November 30, 2020, COVID-19 was diagnosed in 382 persons incarcerated in Idaho correctional facilities with work-release programs. Work-release programs (which place incarcerated persons in community businesses) have social and economic benefits, but might put participants at increased risk for bidirectional transmission of SARS-CoV-2, the virus that causes COVID-19… (CDC MMWR, Apr 23 2021)
(.50 RC) - Aircraft can hold large numbers of persons in close proximity for long periods, which can increase the risk for transmission of infectious disease. Current CDC guidelines recommend against travel for persons who have not been vaccinated against COVID-19, and a January 2021 CDC order requires masking for all persons while on airplanes. Research suggests that seating proximity on aircraft is associated with increased risk for infection with SARS-CoV-2… (CDC MMWR, Apr 23 2021)
(1 RC) - Coccidioidomycosis (Valley fever) is an infection caused by the environmental fungus Coccidioides spp. Approximately 40% of infected persons develop symptoms including fatigue, cough, fever, shortness of breath, and headache, typically after a 1- to 3-week incubation period (1). The infection is often clinically indistinguishable from community-acquired pneumonia caused by other pathogens… (CDC, Sept 2019)
(4 RC) - The uncertainty and change regarding the identification of emerging bacterial agents and the requirements for containment and safe storage of pathogens continues to accelerate. New infectious agents and diseases have emerged. Work with infectious agents in public and private research, public health, clinical and diagnostic laboratories, and in animal care facilities has expanded… (Biosafety in Microbiological and Biomedical Laboratories, Jun 2020)
(4 RC) - The uncertainty and change regarding the identification of emerging bacterial agents and the requirements for containment and safe storage of pathogens continues to accelerate. New infectious agents and diseases have emerged. Work with infectious agents in public and private research, public health, clinical and diagnostic laboratories, and in animal care facilities has expanded… (Biosafety in Microbiological and Biomedical Laboratories, Jun 2020)
(4 RC) - The uncertainty and change regarding the identification of emerging bacterial agents and the requirements for containment and safe storage of pathogens continues to accelerate. New infectious agents and diseases have emerged. Work with infectious agents in public and private research, public health, clinical and diagnostic laboratories, and in animal care facilities has expanded… (Biosafety in Microbiological and Biomedical Laboratories, Jun 2020)
(3 RC) - A fundamental objective of any biosafety program is the containment of potentially hazardous biological agents and toxins. The term containment describes a combination of primary and secondary barriers, facility practices and procedures, and other safety equipment, including personal protective equipment (PPE), for managing the risks associated with handling and storing hazardous biological agents and toxins in a laboratory environment… (Biosafety in Microbiological and Biomedical Laboratories, Jun 2020)
(0.5 RC) - This video discusses additional environmental aspects of legionellosis outbreak investigations, including tips on conducting an environmental assessment and how to interpret the results of key questions on CDC’s Legionella Environmental Assessment Form (www.cdc.gov/legionella/outbreak-toolkit/).
(0.5 RC) - This video discusses environmental aspects of legionellosis outbreak investigations. Learn why and where Legionella amplifies as well as the basics of how cooling towers, premise plumbing, and whirlpool spas work. Content includes a general introduction to environmental health and engineering related to Legionellosis.
(1/2 RC) - This guidance is intended to be pragmatic but sufficiently detailed to allow timely identification of patients experiencing persistent or evolving respiratory complications of COVID-19. Where possible this guidance suggests virtual solutions at relevant points along the patient pathway with the goal of mitigating … (British Thoracic Society, May 2020)
(2 RC) - The purpose of this document is to provide commissioning guidance on the development of a specification to assist local healthcare systems to establish post-COVID assessment clinics for patients experiencing long-term health effects following COVID-19 infection. Clinics will offer physical, cognitive and psychological assessments with the aim of providing consistent … (NHS, Nov. 2020)
(1 RC) - This guidance is for clinicians caring for adults and children admitted to hospital with suspected COVID-19 infection. It does not replace clinical judgement or specialist consultation. COVID-19 infection may present with mild, moderate or severe illness; the latter includes severe pneumonia, acute respiratory distress syndrome (ARDS), sepsis and septic shock. Early recognition of suspected patients… (NHS, Jan. 2020)
Each selection in the LIVE library contains a unique six-digit verification code. Submit the code into the form below to receive credit toward your ACAC recertification.
NOTE: Credits are granted only to individuals who are current ACAC.LIVE subscribers, and can be applied only to the current two-year ACAC recertification period. If you accumulate more than the required number of credits in a single two-year period, keep your subscription current and then wait until after recertification to submit additional verification codes.
CREDIT IS ONLY GIVEN ONCE FOR EACH RESOURCE. Please check your current RC report before sending codes to avoid submitting duplicates.
